The World Federation of Hemophilia (WFH) hosted an educational webinar titled “Progress toward a cure for hemophilia: gene editing explained” on November 25, 2025. In this session, Glenn Pierce, Vice President, Medical, World Federation of Hemophilia (U.S.A.) explored how cutting-edge genetic technologies are reshaping the future of hemophilia care. The objectives of the webinar were to break down the science of gene editing into clear, accessible concepts, explain how gene editing works, and highlight how it differs from other genetic technologies.
The WFH does not engage in the practice of medicine and under no circumstances recommends particular treatment for specific individuals. For diagnosis or consultation on a specific medical problem, the WFH recommends that you contact your physician or local treatment centre. Before administering any products, the WFH urges patients to check dosages with a physician or hemophilia centre staff, and to consult the pharmaceutical company’s printed instructions.
The WFH does not promote any particular pharmaceutical product and any mention of any commercial brand in this presentation is strictly for educational purposes.
A summary of discussions held at the Thirteenth WFH Global Forum on Research and Treatment Products for Bleeding Disorders which
A summary of discussions held at the Twelfth WFH Global Forum on Research and Treatment Products for Bleeding Disorders which
The 3rd edition of the WFH laboratory Manual is the definitive how-to guide for the accurate diagnosis of hemophilia and
The WFH Shared Decision Making (SDM) Workbook is for people with hemophilia A or B and their healthcare team. It
This paper provides an overview of the Turkish method for circumcision in people with hemophilia, as well as appendices of
The WFH Shared Decision Making (SDM) Tool is an interactive decision-support system designed to facilitate discussions regarding treatment options between
